Genmab A/S GNMSF:OTCPK

RT Quote | Exchange | USD
Last | 10:04 AM EDT
298.95quote price arrow down-12.17 (-3.91%)
Volume
263
52 week range
274.93 - 500.92
Loading...
  • Open298.95
  • Day High299.03
  • Day Low298.95
  • Prev Close311.12
  • 52 Week High500.92
  • 52 Week High Date09/02/21
  • 52 Week Low274.93
  • 52 Week Low Date05/12/22

Key Stats

  • Market Cap18,594.37M
  • Shares Out65.49M
  • 10 Day Average Volume5,661.9
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-23.45

KEY STATS

  • Open298.95
  • Day High299.03
  • Day Low298.95
  • Prev Close311.12
  • 52 Week High500.92
  • 52 Week High Date09/02/21
  • 52 Week Low274.93
  • 52 Week Low Date05/12/22
  • Market Cap18,594.37M
  • Shares Out65.49M
  • 10 Day Average Volume5,661.9
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-23.45

RATIOS/PROFITABILITY

  • EPS (TTM)5.41
  • P/E (TTM)55.29
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date08/10/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Genmab A/S

There is no recent news for this security.

Profile

MORE
Genmab A/S is a Denmark-based international biotechnology company. It specializes in the creation and development of antibody therapeutics for the treatment of cancer. The Company is the creator of the approved antibodies: DARZALEX (daratumumab) for the treatment of certain multiple myeloma indications, Kesimpta for the treatment of adults with relapsing forms of multiple sclerosis, TEPEZZA (teprotumumab) for the treatment of thyroid eye disease and FASPRO, for the treatment...
Deirdre Connelly
Independent Chairman of the Board
Jan Van De Winkel Ph.D.
President, Chief Executive Officer
Anthony Mancini
Chief Operating Officer, Executive Vice President
Anthony Pagano
Chief Financial Officer, Executive Vice President
Judith Klimovsky M.D.
Executive Vice President, Chief Development Officer
Address
Kalvebod Brygge 43
Koebenhavn V
1560
Denmark